The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.

CNS Neurosci Ther

Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.

Published: August 2022

GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253729	PMC
http://dx.doi.org/10.1111/cns.13848	DOI Listing

Publication Analysis

receptor agonist

agonist win

win 55212-2

elevated plus-maze

cannabinoid receptor

55212-2 anxiety-like

anxiety-like behavior

behavior locomotion

locomotion genetic

genetic model

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!